ArisGlobal has opened up new opportunities for clinical trial sponsors to use agDisclosure to meet trial registration and disclosure requirements at no cost.
ArisGlobal, a leading provider of solutions to the life science industry has opened up new opportunities for clinical trial sponsors to use agDisclosureTM to meet trial registration and disclosure requirements at no cost. With the release of agDisclosure™ Basic Edition, the company offers a free, entry-level version of its full product in support of trial registration and results disclosure to ClinicalTrials.gov.
agDisclosure Basic Edition is the first and only cloud-based offering that gives life science organizations a no-cost way to efficiently manage the trial registration and results disclosure process for ClinicalTrials.gov. Planning and tracking as well as configurable review and approval workflow functionality ensure the quality, consistency and integrity of data before it is submitted. Pre-recorded training and a user guide enable users to become productive quickly. Interested companies can learn more about this free version at http://totalclinical.com/agdisclosure-free-basic-edition.
“While there are good reasons for making the disclosure of protocol and results data mandatory, the increasing transparency requirements add to the administrative burdens around conducting clinical trials,” states Mathias Poensgen, Product Manager, ArisGlobal. “agDisclosure helps to keep these administrative costs under control by making the trial registration and disclosure process as efficient as possible. Using agDisclosure Basic Edition, companies can experience and evaluate the value this solution delivers over managing the disclosure process manually or using an in-house solution at no cost to their organization.”
The Basic Edition is an entry-level version of the agDisclosure Enterprise Edition, an extended solution that supports trial registration and results reporting to ClinicaTrials.gov, EudraCT and other global registries. The Enterprise Edition, (offered either on premise or hosted on the cloud), provides fuller functionality, including the ability to re-use one entry multiple times across different registries and seamless integration with any CTMS.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.